Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY – Get Free Report) and Journey Medical (NASDAQ:DERM – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership.
Valuation & Earnings
This table compares Shionogi & Co., Ltd. Unsponsored ADR and Journey Medical”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Shionogi & Co., Ltd. Unsponsored ADR | $3.32 billion | 5.14 | $1.35 billion | $0.90 | 11.13 |
| Journey Medical | $61.86 million | 1.78 | -$11.43 million | ($0.18) | -21.65 |
Shionogi & Co., Ltd. Unsponsored ADR has higher revenue and earnings than Journey Medical. Journey Medical is trading at a lower price-to-earnings ratio than Shionogi & Co., Ltd. Unsponsored ADR, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent ratings and price targets for Shionogi & Co., Ltd. Unsponsored ADR and Journey Medical, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Shionogi & Co., Ltd. Unsponsored ADR | 0 | 0 | 0 | 3 | 4.00 |
| Journey Medical | 2 | 0 | 2 | 0 | 2.00 |
Journey Medical has a consensus target price of $13.00, suggesting a potential upside of 233.59%. Given Journey Medical’s higher probable upside, analysts plainly believe Journey Medical is more favorable than Shionogi & Co., Ltd. Unsponsored ADR.
Insider & Institutional Ownership
1.9% of Shionogi & Co., Ltd. Unsponsored ADR shares are owned by institutional investors. Comparatively, 7.2% of Journey Medical shares are owned by institutional investors. 14.5% of Journey Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Volatility and Risk
Shionogi & Co., Ltd. Unsponsored ADR has a beta of 0.1, suggesting that its stock price is 90% less volatile than the S&P 500. Comparatively, Journey Medical has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500.
Profitability
This table compares Shionogi & Co., Ltd. Unsponsored ADR and Journey Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Shionogi & Co., Ltd. Unsponsored ADR | 37.95% | 14.32% | 10.24% |
| Journey Medical | -7.34% | -16.07% | -5.26% |
Summary
Shionogi & Co., Ltd. Unsponsored ADR beats Journey Medical on 10 of the 15 factors compared between the two stocks.
About Shionogi & Co., Ltd. Unsponsored ADR
Shionogi & Co., Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, it has grown from a pharmaceutical wholesaler into a research-focused drugmaker. The company has a particular focus on infectious diseases, including HIV, influenza and COVID-19, and also works in areas such as pain and central nervous system disorders. Its products include Xofluza, an influenza treatment, and ensitrelvir, an oral COVID-19 antiviral marketed in Japan as Xocova.
About Journey Medical
Journey Medical Corporation is a commercial-stage pharmaceutical company focused on developing and marketing prescription treatments for dermatological conditions. Founded in 2014 and based in Scottsdale, Arizona, the company primarily serves the U.S. market. Its portfolio includes treatments for conditions such as acne, rosacea, excessive underarm sweating and fungal skin infections. Products include Amzeeq and Zilxi, topical minocycline therapies; Qbrexza, a topical treatment for primary axillary hyperhidrosis; and the oral rosacea treatment Emrosi.
Receive News & Ratings for Shionogi & Co. Ltd. Unsponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. Unsponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.
